Director, Center For Neuro-Oncology
Dana_Farber Cancer Institute
Boston, Massachusetts, United States
Dr Wen is a Professor of Neurology at Harvard Medical School, Director, Center For Neuro-Oncology, Dana-Farber Cancer Institute and Director, Division of Neuro-Oncology, Department of Neurology at Brigham and Women’s Hospital. He was a former President of the Society For Neuro-Oncology and Editor-In-Chief of Neuro-Oncology and currently SNO Executive Editor of Neuro-Oncology and a member of the Executive Committee of the Response Assessment in Neuro-Oncology (RANO) working group. His research interest is novel therapeutics for brain tumors, as well as novel clinical trial designs and response assessment and endpoints in clinical trials.
(NC5504) Chemotherapy for Gliomas
Monday, April 24, 2023
10:01am – 10:20am PST
Disclosure(s): Astra Zeneca, Bayer, Black Diamond, Boehringer Ingelheim, Boston Pharmaceuticals, Celularity, Chimerix, Day One Bio, Genenta, Glaxo Smith Kline, Karyopharm, Merck, Mundipharma, Novartis, Novocure, Nuvation Bio, Prelude Therapeutics, Sapience, Servi: Advisor (Ongoing), Grant/Research Support (Ongoing)